Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Clears K2M’s Spinal Technology - Orthopedic Design & Technology

What are you searching for?

Sign in
OEM News

FDA Clears K2M’s Spinal Technology

K2M Group Holdings Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Mesa 2 deformity spinal system. Mesa 2 is the company’s next-generation pedicle screw system that is designed to address the most complex spinal pathologies.

The Mesa 2 deformity spinal system features the next-generation Mesa 2 screw, a top-loading, low-profile screw that offers a dual-lead thread pattern for fast insertion. K2M’s Mesa Technology also features zero-torque technology, which offers surgeons the ability to one-step lock without torsional stress being applied to the spine. Both deformity polyaxial and uniplanar screws are available in this new system.

“I am excited about Mesa 2,” said Laurel C. Blakemore, M.D., chief and associate professor of pediatric orthopedics in the department of orthopedics at the University of Florida. “Compared to its predecessor, Mesa 2’s dual-lead thread provides the opportunity for quicker screw insertion and the on/off button on the Crickets provide an easier way for the Crickets to latch on to the Mesa head to help save time during correction.”

The Mesa 2 instrumentation includes upgrades with increased efficiency in mind. For example, the new Quick Cricket, the next generation of K2M’s breakthrough Cricket rod reduction technology, provides quick on/off capabilities, while correcting the spine in all three planes. Additionally, the Over Cricket Final Locker allows for one-step locking over the Cricket, thus eliminating the need to partial lock, the company noted in a news release.

“FDA clearance of Mesa 2 is a milestone event for K2M that further enhances our position in the global complex spine surgery market,” said Eric Major, K2M’s president and CEO. “Mesa 2 carries forward the hallmarks of our Mesa and Cricket rod reduction technologies, while offering new capabilities with the goal of enhancing user experience.”

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Add Orthopedic Design & Technology as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters

Topics